Maria Shvedova

Maria Shvedova

Auto-generated profile, based on publicly available information

Maria Shvedova

Department of Surgery, Division of Plastic and Reconstructive Surgery Boston University Chobanian & Avedisian School of Medicine Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WZWen Zhou
Wen Zhou
PSPetra Simic
Petra Simic
IZIris Y. Zhou
Iris Y. Zhou
PCPeter Caravan
Peter Caravan
XPXavier Vela Parada
Xavier Vela Parada
EREugene P. Rhee
Eugene P. Rhee
How phosphate levels are detected in mammals is unknown. The bone-derived hormone fibroblast growth factor 23 (FGF23) lowers blood phosphate levels by reducing kidney phosphate reabsorption and 1,25(OH)2D production, but phosphate does not directly stimulate bone FGF23 expression. Using PET scanning and LC-MS, we found that phosphate increases kidney-specific glycolysis and synthesis of glycerol-3-phosphate (G-3-P), which then circulates to bone to trigger FGF23 production. Further, we found that G-3-P dehydrogenase 1 (Gpd1), a cytosolic enzyme that synthesizes G-3-P and oxidizes NADH to NAD+, is required for phosphate-stimulated G-3-P and FGF23 production and prevention of hyperphosphatemia. In proximal tubule cells, we found that phosphate availability is substrate-limiting for glycolysis and G-3-P production and that increased glycolysis and Gpd1 activity are coupled through cytosolic NAD+ recycling. Finally, we show that the type II sodium-dependent phosphate cotransporter Npt2a, which is primarily expressed in the proximal tubule, conferred kidney specificity to phosphate-stimulated G-3-P production. Importantly, exogenous G-3-P stimulated FGF23 production when Npt2a or Gpd1 were absent, confirming that it was the key circulating factor downstream of glycolytic phosphate sensing in the kidney. Together, these findings place glycolysis at the nexus of mineral and energy metabolism and identify a kidney-bone feedback loop that controls phosphate homeostasis.

25 April 2026 in Aging Cell
Verified
Journal Article
Open access
MSMaria Shvedova
Maria Shvedova
RTRex Jeya Rajkumar Samdavid Thanapaul
Rex Jeya Rajkumar Samdavid Thanapaul
QWQiaoling Wang
Qiaoling Wang
GSGrace Haeun Shin
Grace Haeun Shin
JDJannat Dhillon
Jannat Dhillon
DRDaniel Roh
Daniel Roh
The transient upregulation of cellular senescence within wound tissues has been demonstrated to be an important biological process facilitating efficient tissue repair. Dysregulation of this transient wound‐induced senescence response can result in impaired healing outcomes. Given the established age‐related decline in tissue regenerative capacity, we hypothesized that alterations in this senescence response contribute to the delayed healing of cutaneous wounds in aged individuals. Our investigation demonstrated a significant delay in the closure of full‐thickness dorsal skin wounds in aged mice compared to their young counterparts. Analysis of the wound microenvironment revealed a transient upregulation of senescence‐associated markers (p16, p21, senescence‐associated β‐galactosidase) and senescence‐associated secretory phenotype factors in the wound tissue of young mice, a response that was markedly attenuated in aged mice. Single‐cell RNA sequencing analysis of all cells isolated from day 6 wounds identified a distinct population of p16 + /p21 + /Ki67 − senescent fibroblasts in young mice, characterized by a transcriptional signature indicative of prohealing extracellular matrix production, a finding corroborated in human wound tissue from young donors. Crucially, in aged wounds, we observed a lower quantity of these senescent cells, a deficit compounded by a qualitative, age‐dependent shift in their function, moving away from beneficial extracellular matrix remodeling toward a more detrimental pro‐inflammatory state, which ultimately can contribute to delayed wound healing.

12 April 2026 in Advances in Wound Care
Verified
Journal Article
Closed access
MSMaria Shvedova
Maria Shvedova
MCMinsung Cho
Minsung Cho
JEJeroen Eyckmans
Jeroen Eyckmans
DRDaniel S. Roh
Daniel S. Roh
Significance: Chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers are characterized by impaired healing and persistent inflammation. Cellular senescence, defined as irreversible growth arrest with a pro-inflammatory secretory phenotype (senescence-associated secretory phenotype), has emerged as a potential driver of these nonhealing states. While transient induction of senescence may aid acute repair, chronic accumulation of senescent cells is thought to disrupt tissue regeneration, promote extracellular matrix degradation, and sustain inflammation. Recent Advances: Single-cell RNA sequencing and spatial transcriptomics have revealed diverse cell states in chronic wounds, including senescent subsets. Studies in diabetic, venous, and pressure ulcers implicate senescent fibroblasts and immune cells in impaired remodeling, often triggered by oxidative stress, hyperglycemia, or ischemia–reperfusion injury. Therapeutic strategies targeting senescent cells in delayed wound healing have demonstrated promise in preclinical models; however, interventions must be timed and targeted precisely. Critical Issues: Despite emerging evidence, the identity, abundance, and location of senescent cells in chronic wounds remain poorly defined. Reliance on nonspecific markers such as p21 or SA-β-gal complicates interpretation. Senescence appears to play context-dependent roles, with beneficial effects during acute healing but harmful persistence in chronic wounds, presenting challenges for therapeutic targeting. Future Directions: More studies using single-cell RNA sequencing, spatial transcriptomics, and longitudinal profiling are needed to define senescent subpopulations, map their spatial distribution, and track dynamics during wound progression. These approaches will help distinguish transient from persistent senescence. A deeper understanding of interactions with immune, epithelial, and stromal components will guide precisely timed, cell type–specific interventions to improve outcomes.

19 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMaria Shvedova
Maria Shvedova
RTRex Jeya Rajkumar Samdavid Thanapaul
Rex Jeya Rajkumar Samdavid Thanapaul
JHJoy Ha
Joy Ha
JDJannat Dhillon
Jannat Dhillon
GSGrace H Shin
Grace H Shin
DRDaniel Roh
Daniel Roh
Senescent cells (SnC) accumulate in aging tissues, impairing their ability to undergo repair and regeneration following injury. Previous research has demonstrated that targeting tissue senescence with senolytics can enhance tissue regeneration and repair by selectively eliminating SnCs in specific aged tissues. In this study, we focused on eliminating SnC skin cells in aged mice to assess the effects on subsequent wound healing. We applied ABT-263 directly to the skin of 24-month-old mice over a 5-day period. Following topical ABT-263, aged skin demonstrated decreased gene expression of senescent markers p16 and p21, accompanied by reductions in SA-β-gal and p21-positive cells compared to DMSO controls. However, ABT-263 also triggered a temporary inflammatory response and macrophage infiltration in the skin. Bulk RNA sequencing of ABT-263-treated skin revealed prompt upregulation of genes associated with wound healing pathways, including hemostasis, inflammation, cell proliferation, angiogenesis, collagen synthesis, and extracellular matrix organization. Aged mice skin pre-treated with topical ABT-263 exhibited accelerated wound closure. In conclusion, topical ABT-263 effectively reduced several senescence markers in aged skin, thereby priming the skin for improved subsequent wound healing. This enhancement may be attributed to ABT-263-induced senolysis which in turn stimulates the expression of genes involved in extracellular matrix remodeling and wound repair pathways.

9 June 2025 in bioRxiv
Verified
Preprint
Open access
MSMaria Shvedova
Maria Shvedova
RTRex Jeya Rajkumar Samdavid Thanapaul
Rex Jeya Rajkumar Samdavid Thanapaul
QWQiaoling Wang
Qiaoling Wang
GSGrace Haeun Shin
Grace Haeun Shin
JDJannat Dhillon
Jannat Dhillon
DRDaniel Roh
Daniel Roh
The transient upregulation of cellular senescence within wound tissues has been demonstrated to be an important biological process facilitating efficient tissue repair. Dysregulation of this transient wound-induced senescence-like response can result in impaired healing outcomes. Given the established age-related decline in tissue regenerative capacity, we hypothesized that alterations in this senescence response contribute to the delayed healing of cutaneous wounds in aged individuals. Our investigation demonstrated a significant delay in the closure of full-thickness dorsal skin wounds in aged mice compared to their young counterparts. Analysis of the wound microenvironment revealed a transient upregulation of senescence-associated markers (p16, p21, senescence-associated β-galactosidase) and senescence-associated secretory phenotype factors in the wound tissue of young mice, a response that was markedly attenuated in aged mice. Single-cell RNA sequencing analysis of all cells isolated from day 6 wounds identified a distinct population of p16 + /p21 + /Ki67 - senescent fibroblasts in young mice, characterized by a transcriptional signature indicative of pro-healing extracellular matrix production, a finding corroborated in human wound tissue from young donors. Crucially, in aged wounds, we observed a lower quantity of these senescent cells, a deficit compounded by a qualitative, age-dependent shift in their function, moving away from beneficial extracellular matrix remodeling towards a more detrimental pro-inflammatory state, which ultimately can contribute to the delayed wound healing.